DHHS Adult ARV Guidelines
Interaction Color Code
Clinical Bottom Line
Do not coadminister: potentially increased levels of disopyramide
Drug 1
Drug 2
Mechanism
Inhibition of CYP3A4 by lenacapavir
Clinical Effects
Potential increased risk of disopyramide adverse effects
Management
Use alternative agents.
Info Source
